Dr. Shah began attended the University of Washington earning a Bachelor’s Degree in Cell and Molecular Biology. He went on to attend Chobanian and Avedisian School of Medicine earning both his Master’s in Graduate Medical Sciences and his M.D./Ph.D. in the Molecular Medicine Program. Dr. Shah completed his Pediatric Residency at Harbor UCLA Medical Center.
Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Molecular and Translational Medicine
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Ando K, Tohme YH, Srinivasiah A, Taylor-Parker J, Harrington Y, Shah AK, Oki E, Brahmandam M, Bharti AK. Developing a Phosphospecific IHC Assay as a Predictive Biomarker for Topoisomerase I Inhibitors. J Histochem Cytochem. 2018 08; 66(8):549-561.View Related Profiles. PMID: 29587004; PMCID: PMC6071180; DOI: 10.1369/0022155418766503;
Ando K, Shah AK, Sachdev V, Kleinstiver BP, Taylor-Parker J, Welch MM, Hu Y, Salgia R, White FM, Parvin JD, Ozonoff A, Rameh LE, Joung JK, Bharti AK. Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway. Oncotarget. 2017 Jul 04; 8(27):43733-43751.View Related Profiles. PMID: 28415827; PMCID: PMC5546437; DOI: 10.18632/oncotarget.16376;
Shah A, Singh H, Sachdev V, Lee J, Yotsukura S, Salgia R, Bharti A. DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER. Curr Proteomics. 2010 Apr 01; 7(1):49-65.View Related Profiles. PMID: 20526421; PMCID: PMC2880513
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.